APVO - Aptevo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-226491.71. This is a potential upside of $-226493.12 (-16063341.84%) from yesterday's end of day stock price of $1.41.

Aptevo Therapeutics's activity chart (see below) currently has 7 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 184 days.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Nov-2018.

Best performing analysts who are covering APVO - Aptevo Therapeutics:

Wangzhi Li Edward Tenthoff Jonathan Aschoff

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 years 13 days ago
(23-Sep-2024)

0/2 (0%)

$38876.64 (91.42%)

Buy

$112332

3 years 1 months 24 days ago
(12-Aug-2022)

5/5 (100%)

$-37444 (-25.00%)

379

Buy

$319088

4 years 10 months 27 days ago
(09-Nov-2020)

2/2 (100%)

$-680912 (-68.09%)

173

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APVO (Aptevo Therapeutics) average time for price targets to be met?

On average it took 184 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?

WANGZHI LI

Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?

Wangzhi Li has 5 price targets and 3 ratings on APVO

Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?

Wangzhi Li with highest potential upside - $0

Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?